Phase I Study of HRS-6093 in Participants With Advanced Solid Tumors Harboring KRAS G12D Mutations

Clinical trial NCT07134998 · RECRUITING

Trial details

NCT number: NCT07134998
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced KRAS G12D Mutant Solid Tumors

Start date: 2025-09-16
Primary completion: 2028-05-01
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.